196 related articles for article (PubMed ID: 28759842)
1. Determination of vitacoxib, a novel COX-2 inhibitor, in equine plasma using UPLC-MS/MS detection: Development and validation of new methodology.
Wang J; Zhao T; Kong J; Peng H; Lv P; Li J; Cao X; Zhang S
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Sep; 1061-1062():270-274. PubMed ID: 28759842
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of pharmacokinetic properties of vitacoxib in fasted and fed horses.
Wang J; Xue J; Kong J; Li J; Zhang S; Cao X
J Vet Pharmacol Ther; 2018 Dec; 41(6):843-847. PubMed ID: 30076623
[TBL] [Abstract][Full Text] [Related]
3. UPLC-MS/MS method for the simultaneous quantification of sofosbuvir, sofosbuvir metabolite (GS-331007) and daclatasvir in plasma of HIV/HCV co-infected patients.
Notari S; Tempestilli M; Fabbri G; Libertone R; Antinori A; Ammassari A; Agrati C
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jan; 1073():183-190. PubMed ID: 29276983
[TBL] [Abstract][Full Text] [Related]
4. A semi-automated LC-MS/MS method for the determination of LCI699, a steroid 11β-hydroxylase inhibitor, in human plasma.
Li W; Luo S; Rebello S; Flarakos J; Tse FL
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jun; 960():182-93. PubMed ID: 24814004
[TBL] [Abstract][Full Text] [Related]
5. UPLC-MS/MS assay of 21-aminosteroid (lazaroid U74389G) for application in pharmacokinetic study.
Gadgil P; Ibrahim F; Chow DS
J Pharm Biomed Anal; 2016 Apr; 122():90-7. PubMed ID: 26848737
[TBL] [Abstract][Full Text] [Related]
6. Validated UPLC/MS/MS assay for quantitative bioanalysis of elbasvir in rat plasma and application to pharmacokinetic study.
Liu H; Xu H; Song W; Zhang Y; Yu S; Huang X
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Mar; 1015-1016():150-156. PubMed ID: 26927874
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of the novel COX-2 selective inhibitor vitacoxib in cats: The effects of feeding and dose.
Wang J; Gong X; Xue J; Zhang S; Li J; Cao X
J Vet Pharmacol Ther; 2019 May; 42(3):294-299. PubMed ID: 30737806
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of an LC-MS/MS method for the determination of SB-505124 in rat plasma: Application to pharmacokinetic study.
Jiang J; Zhang Y; Zhang Q; Li Y; Gong T; Zhang Z; Ding R; Sun X
J Pharm Biomed Anal; 2016 Jan; 117():205-9. PubMed ID: 26363490
[TBL] [Abstract][Full Text] [Related]
9. Detection and quantification of cimicoxib, a novel COX-2 inhibitor, in canine plasma by HPLC with spectrofluorimetric detection: development and validation of a new methodology.
Giorgi M; Kim TW; Saba A; Rouini MR; Yun H; Ryschanova R; Owen H
J Pharm Biomed Anal; 2013 Sep; 83():28-33. PubMed ID: 23685411
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of sensitive and rapid UPLC-MS/MS method for quantitative determination of daclatasvir in human plasma: Application to a bioequivalence study.
Rezk MR; Bendas ER; Basalious EB; Karim IA
J Pharm Biomed Anal; 2016 Sep; 128():61-66. PubMed ID: 27232152
[TBL] [Abstract][Full Text] [Related]
11. Validated UPLC-MS/MS assay for the determination of synthetic phosphodiesterase type-5 inhibitors in postmortem blood samples.
Proença P; Mustra C; Marcos M; Franco JM; Corte-Real F; Vieira DN
J Forensic Leg Med; 2013 Aug; 20(6):655-8. PubMed ID: 23910856
[TBL] [Abstract][Full Text] [Related]
12. Determination and pharmacokinetic study of pirfenidone in rat plasma by UPLC-MS/MS.
Sun W; Jiang ZL; Zhou L; Chen RM; Wang Z; Li WS; Jiang SM; Hu GX; Chen RJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Feb; 981-982():14-8. PubMed ID: 25596380
[TBL] [Abstract][Full Text] [Related]
13. An LC-MS/MS method for the quantitation of cabozantinib in rat plasma: application to a pharmacokinetic study.
Su Q; Li J; Ji X; Li J; Zhou T; Lu W; Li L
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Mar; 985():119-23. PubMed ID: 25678398
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous determination of olmesartan and amlodipine in human plasma and urine by ultra performance liquid chromatography tandem mass spectrometry.
Qi W; Zhao Q; Jiang J; Hu P
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Nov; 938():27-34. PubMed ID: 24036499
[TBL] [Abstract][Full Text] [Related]
15. Determination of acacetin in rat plasma by UPLC-MS/MS and its application to a pharmacokinetic study.
Fan LH; Li X; Chen DY; Zhang N; Wang Y; Shan Y; Hu Y; Xu RA; Jin J; Ge RS
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Apr; 986-987():18-22. PubMed ID: 25703948
[TBL] [Abstract][Full Text] [Related]
16. Determination of kurarinone in rat plasma by UPLC-MS/MS.
Zhang WM; Li RF; Qiu JF; Zhang ZY; Wang HB; Bian L; Lei JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Apr; 986-987():31-4. PubMed ID: 25703950
[TBL] [Abstract][Full Text] [Related]
17. UPLC-MS/MS method for determination of avicularin in rat plasma and its application to a pharmacokinetic study.
Zhang WM; Li RF; Sun M; Hu DM; Qiu JF; Yan YH
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Aug; 965():107-11. PubMed ID: 25010713
[TBL] [Abstract][Full Text] [Related]
18. Development and Validation of a Simple and Rapid UPLC-MS Assay for Valproic Acid and Its Comparison With Immunoassay and HPLC Methods.
Zhao M; Li G; Qiu F; Sun Y; Xu Y; Zhao L
Ther Drug Monit; 2016 Apr; 38(2):246-52. PubMed ID: 26488205
[TBL] [Abstract][Full Text] [Related]
19. An UPLC-MS/MS method for the quantitation of alectinib in rat plasma.
Huang XX; Li YX; Li XY; Hu XX; Tang PF; Hu GX
J Pharm Biomed Anal; 2017 Jan; 132():227-231. PubMed ID: 27768922
[TBL] [Abstract][Full Text] [Related]
20. Rapid determination of fenoldopam in human plasma by UPLC-MS/MS for pharmacokinetic analysis in patients.
Wang X; Zheng Z; He G; Mai L; Zhou Z; Zhong S; Lin Q; Shan Z; Deng C; Yang M; Yu X
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jan; 978-979():78-82. PubMed ID: 25531873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
